Reprogramming Supervisor
United Therapeutics Corporation
Reprogramming Supervisor
United Therapeutics Corporation
Biotech company develops PAH therapies
California, US residentsclick here.
The job details are as follows:
Who We Are
We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs.
United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter’s pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF).
The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
Who You Are
Lead from the bench and help advance the next generation of cell-based manufacturing. As Supervisor, Reprogramming (iPSC), you will guide a team of Manufacturing Associates while working alongside them to reprogram and scale induced pluripotent stem cells (iPSCs) in a phase-appropriate GMP environment. You will set the pace for safe, compliant, and efficient day-to-day operations, ensuring work is executed in accordance with GMP principles, established procedures, and safety protocols. This is an opportunity for a hands-on leader to combine technical expertise with people leadership and make a meaningful impact on the development of robust, scalable iPSC manufacturing processes.
Minimum Requirements
Preferred Qualifications
Job Location
United Therapeutics requires this role to be 100% onsite in our Silver Spring, MD office.
The salary range for this position is $37.98 - $50.48/hour and reflects our good-faith estimate of the compensation for this role at the time of posting. An employee’s position within the salary range will be based on factors such as education, qualifications, experience, skills, geographic location, and business needs, as well as other factors permitted by law at the time of posting. This range may be modified in the future based on company and market factors.
At United Therapeutics, our mission and vision are one. We use our enthusiasm, creativity, and persistence to innovate for the unmet medical needs of our patients and to benefit our other stakeholders. We are bold and unconventional. We have fun, we do good.
Eligible employees may participate in the Company’s comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more. For additional information on Company benefits, please visit https://www.unither.com/careers/benefits-and-amenities
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.
Biotech company develops PAH therapies
United Therapeutics develops medicines for pulmonary arterial hypertension and other rare diseases, and pursues organ manufacturing through its Xenotransplantation efforts. Its drugs are given as oral tablets, intravenous infusions, or inhaled therapies to open damaged lung vessels and support heart function, while its organ programs aim to create bioengineered organs from donor animals to reduce rejection. The company differentiates itself by pairing a pharmaceutical portfolio with regenerative medicine and organ manufacturing, and by operating as a public-benefit corporation with sustainable facilities. Its goal is to end the organ transplant shortage by supplying transplantable organs while improving patient outcomes through better drug delivery and regenerative medicine.
Explore more opportunities at United Therapeutics Corporation